UNIVERSITAT ZURICH PROREKTORAT MNW Patent applications |
Patent application number | Title | Published |
20150284463 | BISPECIFIC HER2 LIGANDS FOR CANCER THERAPY - The invention relates to a bispecific HER2-targeting agent comprising a.) a first polypeptide ligand that binds to HER2 extracellular domain 1, b.) a second polypeptide ligand that binds to HER2 extracellular domain 4 and c.) a linker covalently attaching said first polypeptide ligand to said second polypeptide ligand. | 10-08-2015 |
20140324078 | Device for Repair Surgery of Cylindrical Organs, Particularly Ruptured Tendons - A device for repair surgery of cylindrical organs, particularly ruptured tendons, is configured as a tubular sheath (T) made of a biocompatible and biodegradable polymer. The tubular sheath comprises an elastic fiber mesh formed by electrospinning of said polymer and has an inner wall surface and an outer wall surface substantially parallel thereto. One of said wall surfaces is comparatively rough (W | 10-30-2014 |
20140193366 | Modulators of miR-323-3p for the Prevention or Treatment of Rheumatoid Arthritis - A miR-323-3p inhibitor is provided for the prevention or therapy of rheumatoid arthritis, comprising a sequence capable of forming a hybrid to miR-323-3p as an oligonucleotide or a vector from which such oligonucleotide is transcribed, or as a miRNA decoy or sponge. | 07-10-2014 |
20110218233 | TREATMENT OF SCLERODERMA - The present invention provides a method of treating scleroderma. The method consists in the upregulation of miR-29 by administration of miR-29 or a miR-29 upregulator which elevates circulating and/or intracellular concentrations of miR-29. The invention likewise relates to the use of miR-29 for such a treatment, and the use of miR-29 for the manufacture of a medicament for the treatment of scleroderma. | 09-08-2011 |